USPTO serial 79369113
EPIDEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 13, 2024
- Examiner
- HARMON, RAYMOND E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EPIDEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Barry I. Friedman
Barry I. Friedman Metz Lewis Brodman Must O'Keefe LLC444 Liberty Avenue, Suite 2100Pittsburgh, PA 15222United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for use in tissue regeneration and wound healing in the management of acute and chronic wounds and rare diseases; enzymes for medical use; pharmaceutical preparations for wound healing in the management of acute and chronic wounds and rare diseases; cells for medical use; living cells for medical use; pharmaceutical preparations containing stem cells for wound healing in the management of acute and chronic wounds and rare diseases; stem cells for medical use; stem cells for veterinary use; transplants being implants comprising living tissue; surgical implants made from living tissues; surgical implants grown from stem cells being living tissue; bone void fillers made from living tissues; tissue-regenerative pharmaceutical preparations; enzymes for veterinary use; all the above mentioned goods not related to the treatment of epilepsy or other neurological disorders | ACTIVE | — |
| 042 | Tissue engineering, namely, genetic engineering of human tissue for others; Analysis of human tissues for medical research; scientific research services, namely, the isolation and cultivation of human tissues and cells; genetic engineering services; scientific research in the field of genetics and genetic engineering; advisory services relating to gene therapy research; research in the field of gene therapy; all the above-mentioned services not related to the treatment of epilepsy or other neurological disorders | ACTIVE | — |
| 044 | Stem cell therapy services; medical services, namely, analysis of human tissues for medical treatment purposes; stem cell bank services for medical transplantation; medical services, namely, the removal, treatment and processing of stem cells; medical services, namely, the removal, treatment and processing of human cells; medical and health care services, namely, DNA screening for medical purposes, genetics counseling and genetic testing for medical purposes; genetic testing for medical use; genetic counseling; regenerative medicine services; medical services in the field of treatment of chronic conditions; medical services in the field of injury healing; all the above-mentioned services not related to the treatment of epilepsy or other neurological disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Healiva SA
- Other trademarks owned by Healiva SA
- Other trademarks owned by Healiva SA
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named EPIDEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 22, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 5, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 5, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 13, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 13, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 13, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 28, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 28, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 8, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 25, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 25, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 25, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 25, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 26, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 26, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 19, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 18, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 2, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 16, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 12, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 11, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |